Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | GNE-272 |
Synonyms | |
Therapy Description |
GNE-272 is an inhibitor targeting the bromodomains of CREBBP and EP300, which subsequently prevents MYC expression, thereby potentially resulting in anti-proliferative effects and tumor growth inhibition (PMID: 27682507). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GNE-272 | CBP/p300 inhibitor 11 | GNE-272 is an inhibitor targeting the bromodomains of CREBBP and EP300, which subsequently prevents MYC expression, thereby potentially resulting in anti-proliferative effects and tumor growth inhibition (PMID: 27682507). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|